The issue: Availability of piperacillin/tazobactam 2.25 g and 4.5 g vials remains limited in Canada and NH supply may not be sufficient to maintain usual needs at all sites. Anticipated availability: December 2024
Newsroom
The Issue: availability of bupivacaine HCl 0.25% and 0.5% with EPINEPHrine 1:200,000 X 20 mL vials remains limited and NH supply may not be sufficient each month to maintain usual needs.
The issue: Hydralazine 20 mg/mL x 1 mL injectable is on backorder from the only manufacturer in Canada. NH has approximately six weeks of stock in pharmacies and patient care areas and may be at risk of stock outs if the resupply date gets pushed into the new year.
Do you have a patient who has been or know of a caregiver for someone who has been discharged from the Intensive Care Unit in Northern Health in the past two years? If so, we need your help!
The issue: Dihydroergotamine 1 mg/mL injectable
Stock status: Dihydroergotamine injectable is on backorder from Sterimax until mid February 2025. All supplies of dihydroergotamine injectable will expire at the end of October 2024.
The Prince George Rapid Mobilization Program was created in 2015 to assist acute care clients with their transition home after hospital admission and/or to connect client’s to longer term community based home support services.
The Issue: Due to the ongoing shortage of bupivacaine 0.5% with EPINEPHrine (1:200,000) vials in Canada, Health Canada has approved the importation of an equivalent Danish-authorized product from Aspen Pharmacare Inc.